GLENN P MUIR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GLENN P MUIR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN P MUIR. GLENN P MUIR is Director in REPLIGEN CORP ($RGEN) and Director in Neuronetics, Inc. ($STIM) and in G1 Therapeutics, Inc. ($GTHX) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in ReWalk Robotics Ltd. ($RWLK).
Latest Insider Trading Transactions of GLENN P MUIR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GTHX, STIM, RGEN, RWLK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2020 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Buy | P | 13.50 | 50,000 | 675,000 | 170,969 | 121 K to 171 K (+41.33 %) | |
Nov 19 2020 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Buy | P | 13.50 | 50,000 | 675,000 | 170,969 | 121 K to 171 K (+41.33 %) | |
Aug 07 2020 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 18,513 | 0 | 82,236 | 63.7 K to 82.2 K (+29.05 %) |
Jun 12 2020 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Option Exercise | A | 17.59 | 20,000 | 351,800 | 20,000 | |
May 28 2020 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 20,000 | 0 | 63,723 | 43.7 K to 63.7 K (+45.74 %) |
May 28 2020 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 20,000 | 0 | 63,723 | 43.7 K to 63.7 K (+45.74 %) |
May 19 2020 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 128.18 | 1,285 | 164,711 | 1,285 | |
May 19 2020 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Grant | A | 0.00 | 527 | 0 | 5,905 | 5.4 K to 5.9 K (+9.80 %) |
Jun 14 2019 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Option Exercise | A | 18.47 | 20,000 | 369,400 | 20,000 | |
May 30 2019 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Option Exercise | A | 13.43 | 7,347 | 98,670 | 7,347 | |
May 30 2019 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Option Exercise | A | 13.43 | 7,347 | 98,670 | 7,347 | |
May 30 2019 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 3,723 | 0 | 43,723 | 40 K to 43.7 K (+9.31 %) |
May 30 2019 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 3,723 | 0 | 43,723 | 40 K to 43.7 K (+9.31 %) |
May 17 2019 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 67.71 | 2,109 | 142,800 | 2,109 | |
May 17 2019 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Grant | A | 0.00 | 923 | 0 | 5,378 | 4.5 K to 5.4 K (+20.72 %) |
Jul 05 2018 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Option Exercise | A | 5.22 | 8,767 | 45,764 | 8,767 | |
Jul 05 2018 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Buy | P | 17.00 | 40,000 | 680,000 | 40,000 | 0 to 40 K |
Jun 11 2018 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Option Exercise | A | 38.39 | 10,000 | 383,900 | 10,000 | |
May 17 2018 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 42.07 | 3,304 | 138,999 | 3,304 | |
May 17 2018 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Grant | A | 0.00 | 1,486 | 0 | 4,455 | 3 K to 4.5 K (+50.05 %) |
Jul 13 2017 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Option Exercise | A | 15.55 | 20,000 | 311,000 | 20,000 | |
Jun 29 2017 | RWLK | ReWalk Robotics Lt ... | MUIR GLENN P | Director | Option Exercise | A | 2.10 | 4,176 | 8,770 | 4,176 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Option Exercise | C | 0.00 | 302,908 | 0 | 0 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Buy | P | 15.00 | 20,000 | 300,000 | 120,969 | 101 K to 121 K (+19.81 %) |
May 24 2017 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Buy | C | 0.00 | 100,969 | 0 | 100,969 | 0 to 101 K |
May 22 2017 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 38.76 | 2,434 | 94,342 | 2,434 | |
May 22 2017 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Grant | A | 0.00 | 1,206 | 0 | 2,969 | 1.8 K to 3 K (+68.41 %) |
May 26 2016 | RWLK | ReWalk Robotics Lt ... | MUIR GLENN P | Director | Option Exercise | A | 8.70 | 4,176 | 36,331 | 4,176 | |
May 13 2016 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 26.12 | 3,366 | 87,920 | 3,366 | |
May 13 2016 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Grant | A | 0.00 | 1,763 | 0 | 1,763 | 0 to 1.8 K |
Sep 16 2015 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 36.29 | 24,000 | 870,960 | 24,000 |
Page: 1